期刊文献+

乳腺癌脑转移治疗研究新进展 被引量:1

下载PDF
导出
摘要 乳腺癌发生脑转移仅次于肺癌,近年来乳腺癌脑转移的发生率不断升高,一旦出现脑转移,将对患者生存时间及生活质量产生严重影响[1]。乳腺癌脑转移虽已属晚期,但随着其治疗手段的不断发展,对患者的治疗带来了福音。但出现远处脑转移患者的疗效仍不乐观,且尚无统一治疗方案[2]。乳腺癌脑转移的治疗主要是通过局部治疗和全身治疗,近年来在综合治疗方面取得了较多最新进展。现将乳腺癌脑转移治疗方法的最新进展综述如下。
作者 张力 刘胜春
出处 《现代医药卫生》 2016年第20期3157-3159,共3页 Journal of Modern Medicine & Health
  • 相关文献

参考文献23

  • 1Tayyeb B, Parvin M. Pathogenesis of breast cancer metastasis to brain : a comprehensive approach to the signaling network[J]. Mol Neurobiol, 2016,53(1 ) : 446-454.
  • 2Gil-Gi l~IJ ,Martinez-Gareia M ,Sierra A ,et al. Breast eaneer brain metas- tases : a review of the literature and a current multidisciplinary manage- ment gnideline[J]. Clin Transl Oneo1,2014,16(5) :436-446.
  • 3Hofer S, Pestalozzi BC. Treatment of breast cancer brain metastases[J]. Eur J Pharmaeol, 2013,717 ( 1/3 ) : 84-87.
  • 4Koeher M,Soffietti R,Abaeioglu U,et al. Adjuvant whole-brain radiotherapyversus observation after radiosurgery or surgical resection of one to three cerebral metastases :results of the EORTC 22952-26001 study[J]. J Clin Oncol,2011,29(2) :134-141.
  • 5Patil R, Ljubimov AV, Gangalum PR, et al. MRI virtual biopsy and treat- ment of brain metastatic tumors with targeted nanobioconjugates :nan- oclinic in the brain[J]. ACS Nano, 2015,9 (5) : 5594-5608.
  • 6Nieder C, Marienhagen K, Astner ST. Prognostic scores in brain metastases from breast cancer[J]. BMC Cancer, 2009,9 (9) : 105-114.
  • 7Li J, Bentzen SM, Renschler M, et al. Regression after whole-brain radia- tion therapy for brain metastases correlates with survival and improved neurocognitive function[J]. J Clin Oncd,2007,25 (10) : 1260-1266.
  • 8Poll GL, Bianchi C, Virotta G, et al. Radretumab radioimmunotherapy in patients with brain metastasis:a 124I-L19SIP dosimetric PET study [J]. Cancer Immunol Res, 2013,1 (2) : 134-143.
  • 9Sire HW, Morris PG, Patil S,et al. Brain metastases in breast cancer [J]. Expert Rev Anti Cancer Ther, 2014,14(2) : 173-183.
  • 10Kwon KY ,Kong DS,I_e~ JI,et al. Outcome of repeated radiosurgary for recurrent metastatic brain tumors[J]. Clin Neurol Neurosurg,2007,109 (2) : 132-137.

二级参考文献10

  • 1Wikman H, Sielaff-Frimpong B, Kropidlowski J, et al. Clinical relevance of loss of llp15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases. PLoS One ,2012,7 (10) : e47537.
  • 2Chiba A, Shimizu S, Yoshida A, et al. Efficacy and toxicity of lapatinib plus capecitabine therapy in HER2-positive metastatic breast cancer. Gan To Kagaku Ryoho,2012,39( 11 ) :1675-1679.
  • 3Vern-Gross TZ, Lawrence JA, Case LD, et al. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol,2012,110 (3) :381-388.
  • 4Hameed H, Cassidy J. Use of capecitabine in management of early colon cancer. Cancer Manag Res ,2011,3:295-299.
  • 5Siedentopf F, Gohler T, Hesse T, et al. Capecitabine in the routine treatment of Advanced breast cancer: results from a non- interventional observational study in 876 patients. Onkologie,2009, 32( 11 ) :631-636.
  • 6Fujita Y,Mizuta N,Sakaguchi K,et al. A case of effective lapatinib/ capecitabine therapy for HER2-positive breast cancer with multiple brain metastases. Gan To Kagaku Ryoho, 2012, 39 (11): 1699-1702.
  • 7Conroy T, Hebbar M, Bennouna J, et al. Quality-of-life findings from a randomised phase- III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. Br J Cancer, 2010,102( 1 ) :59-67.
  • 8Tse VC, Ng WT, Lee V, et al. Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision- making on reimbursement. BMC Cancer,2011,11:288.
  • 9李艳,王丕琳,宋茂民,尹子毅.乳腺癌脑转移治疗的研究进展[J].中国癌症杂志,2009,19(4):313-317. 被引量:9
  • 10谢联斌,谢莉,袁丽方.多西紫杉醇联合卡培他滨治疗蒽环类耐药晚期三阴性乳腺癌的临床观察[J].中华乳腺病杂志(电子版),2010,4(3):61-62. 被引量:25

共引文献6

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部